MARKETING AGREEMENT


THIS MARKETING AGREEMENT  ("Agreement") is entered into effective as of the (21)
day of February 2006, by and between Trillennium Medical Imaging,  Inc. a wholly
owned subsidiary of Wellstar  International,  Inc., a Nevada  Corporation having
its  principal  place  of  business  in  Ohio,  ("Licensor")  and  Marty  Ellis,
President, Allevia Medical, ("Rep.").

                                   WITNESSETH:

WHEREAS,  Licensor holds the exclusive rights to certain advanced,  FDA approved
thermal  imaging  cameras,  related  software and equipment,  (the  "Trillennium
System")  and has the  ability  to provide  related  training  services,  all as
further specified herein (the "Trillennium Services"); and

WHEREAS,  the Trillennium System  incorporates  certain patents,  patent pending
applications,   proprietary   inventions,   know-how,   and  other  Confidential
Information (the "Licensed Technology"); and

WHEREAS,  Rep. has existing or seeks to develop  relationships with certain pain
clinics,  imaging  clinics,  wound care  facilities,  hospitals,  nursing homes,
nursing  home  management  companies,   ambulatory  care  facilities  and  other
healthcare providers in which Rep. believes it will be beneficial to utilize the
Trillennium System; and

WHEREAS,  Licensor  desires  to  appoint  Rep.  as its  non-exclusive  Marketing
Representative   for  the  purpose  of  assisting   Licensor  in  expanding  its
Trillennium Services client base, it is

NOW, THEREFORE,  AGREED, in consideration of the mutual promises set forth below
and other good and valuable consideration,  the receipt and sufficiency of which
all parties hereto hereby acknowledge, as follows:

1.   Recitals.   The  above   recitals  are  true  and  correct  and  are  fully
     incorporated into the body of this Agreement as if fully rewritten herein.

2.   Definitions.

     a.   "Commencement  Date"  means the date upon which Rep.  places its first
          order  for  Thermal  Imaging  Systems  in  accord  with the  terms and
          conditions hereof.

     b.   "Confidential  Information" means and collectively includes all secret
          and  confidential  Technical  Information,   as  hereinafter  defined,
          including all specifications,  data, drawings, explicated know-how and
          experience,   trade   secrets,   software,   databases,    proprietary
          information  and any documents  owned by Licensor which pertain to the
          Thermal Imaging  Cameras and/or is used in the  Trillennium  Services,
          including  but not limited to the Licensed  Technology,  to the extent
          that such  information:  (i) was not known to the recipient;  (ii) was
          not  disclosed  in  published  literature;  (iii)  was  not  generally
          available in the  industry;  and/or (iv) has not been  divulged to the
          recipient by a third party.

     c.   "Licensed  Rights"  means and includes the right to obtain and use the
          Trillennium  System in Rep.'s  present or future pain  and/or  imaging
          clinics or such other  entities  with  which Rep.  shall  successfully
          arrange a License Agreement for the use of the Trillennium System.

     d.   "Technical  Information"  means  unpublished  research and development
          information,  market and business  information,  patented  inventions,
          patent   applications,    know-how,   trade   secrets,   manufacturing
          information, computer programs and computer design programs, technical
          data and  management  or  supervisory  know-how in the  possession  of
          Licensor as of the  Commencement  Date, or as  subsequently  acquired,
          developed,  produced or otherwise  available to the Licensor following
          the Commencement Date and throughout the term of this Agreement.
<PAGE>
3.   Enhancements.

     a.   Licensor shall  promptly  notify Rep. of any and all  enhancements  or
          improvements  (hereinafter  all  included in the term  "Enhancements")
          relating to the Trillennium Services, including but not limited to the
          Trillennium   System  and/or   Licensed  Rights  which  are  hereafter
          developed by the Licensor, and Rep. shall have the right to market all
          such   Enhancements,   subject  to  such   reasonable  fees  for  such
          Enhancements   as  Licensor   may,  in  its  sole   discretion,   deem
          appropriate,  as  though  originally  included  in the grant of rights
          hereunder.

     b.   Rep.  agrees  that it will  notify  Licensor  of any  Enhancements  it
          develops or  discovers.  Rep.  hereby  grants to Licensor the right to
          unencumbered  use and to secure  patent  rights  in such  Enhancements
          developed by Rep. as part of the  consideration  received by Rep. from
          Licensor for the right to market the Trillennium  Services as provided
          for herein.

4.   Repair and Maintenance.  Rep. agrees to immediately  notify Licensor of any
     defects in any equipment or other materials  provided by Licensor  pursuant
     to  the  terms  of  this   Agreement.   Any  repairs  and/or   replacements
     necessitated  by the negligence  and/or  intentional  acts of Rep.,  Rep.'s
     employees,  agents,  contractors  or other invitees shall be made at Rep.'s
     sole expense. 5. Nondisclosure of Confidential Information.

     a.   All  Confidential  Information  and/or  materials  made  available  by
          Licensor to Rep.  hereunder  shall remain so until such time, if ever,
          as the material is no longer confidential through no action,  inaction
          or fault of Rep. and shall be kept and maintained as confidential  and
          shall  not be  disclosed  by  Rep.  to any  third  party  unless  such
          information and/or materials are published or enter the public domain.

     b.   For the  purposes of  compliance  with the privacy  provisions  of the
          Health Insurance  Portability and  Accountability Act of 1996 (HIPAA),
          Rep.  and  Licensor's  relationship  with each  other are as  "Covered
          Entities." As used hereunder,  the terms "Covered Entity",  "Protected
          Health  Information",  "use" and "disclosure"  shall have the meanings
          ascribed to them in 42 CFR Section 164.501.

     c.   Rep. and the Licensor each agree to conduct their respective  business
          in accordance  with all  applicable  laws and  regulations,  including
          HIPAA and the regulations promulgated thereunder.

6.   Marketing Rights and Obligations.

     a.   Licensor appoints Rep. as its non-exclusive  Marketing  Representative
          for the purpose of facilitating  Trillennium System  installations and
          License   arrangements   (each  an   "Arrangement"   and  collectively
          "Arrangements")  between  Licensor  and  such  third  parties  (each a
          "Prospect" and  collectively  "Prospects")  that (a) are introduced to
          Licensor by Rep. and/or its agents and/or  representatives  during the
          Term (defined below) hereof and (b) with whom Licensor does not have a
          pre-existing  relationship  (whether  business or personal)  with such
          Prospect  or its  representatives  (as  evidenced  by the  records  of
          Licensor)  (a   "Pre-existing   Relationship").   If  a   Pre-existing
          Relationship  is in place  Licensor will notify Rep.  within three (3)
          business  days of the date on which a Prospect's  name is presented if
          Licensor has a Pre-existing  Relationship with such Prospect, and will
          promptly  thereafter  provide Rep. with evidence from Licensor records
          of such Pre-existing Relationship.  Rep. accepts such appointment, and
          agrees to use its best efforts to facilitate such Arrangements.

                                       2
<PAGE>
     b.   Rep. agrees that during the Term hereof,  any extension thereof or for
          so long as Licensor  shall be paying  Commissions to Rep. for services
          rendered hereunder, Rep. shall neither market, represent nor recommend
          any  product  or  service  competing,  directly  or  indirectly,  with
          Licensor's Trillennium System or any component thereof.

     c.   With regard to Rep.'s marketing activities, Rep. agrees that:

          i.   Licensor  may,  at  Licensor's  sole  option,  be involved in all
               planning and marketing presentations;

          ii.  Rep.'s right to  participate  in any seminars,  trade show,  etc,
               with Licensor  shall be at Licensor's  sole  discretion,  on such
               terms and conditions as Licensor,  shall, in it's sole discretion
               determine, on a case by case basis;

          iii. All pricing, use fee and other financial  determinations shall be
               determined solely by Licensor, in Licensor's sole discretion, and
               Rep.  shall  not  make  any  representations  regarding  the same
               without Licensor's express written consent;

          iv.  Rep.  understands  and agrees  that in the event Rep.  introduces
               another  individual or group which Licensor agrees to engage as a
               marketing  representative,  then and in that  event,  Rep.'s sole
               compensation  arising  therefrom  or from any business or fees of
               any kind or  nature  generated  from or  through  such  marketing
               representative  shall be in the form of a credit of the number of
               timely  paid not  repeat  imaging  sessions  generated  from such
               accounts  to  Rep.'s  order for  purpose  of  calculating  Rep.'s
               entitlement to stock bonus(es) in accord with Schedule A attached
               hereto.

7.   No Obligation to Consummate  Arrangement or  Installations;  No Fees Unless
     Arrangement Consummated.  Licensor is under no obligation to consummate any
     Arrangement with any Prospect(s) or to place its Trillennium  System in any
     location  requested  by  Rep.  or to  continue  any  such  installation  or
     Arrangement  unless Licensor,  in its sole discretion,  determines it is in
     its best interest to do so.  Notwithstanding  anything in this Agreement to
     the contrary,  Licensor is under no obligation  to pay any  Commission  (or
     other consideration  whatsoever) to Rep. under this Agreement or otherwise,
     unless Licensor has received the payment from which such commission  arises
     from a particular Prospect,  with whom Licensor does not have a Preexisting
     Relationship,  under an Arrangement  entered into during the Term. Licensor
     is free to consummate an Arrangement without obligation to Rep. at any time
     with any person or entity that is not a Prospect or with any Prospect  with
     whom Licensor has a Preexisting Relationship.

                                       3
<PAGE>
8.   Commissions

     a.   The parties  acknowledge  and agree that Rep.  will spend  substantial
          amounts of time, energy and expense to introduce Licensor to Prospects
          who may be interested in entering into an  Arrangement  with Licensor.
          Rep. will facilitate  Arrangements  between Licensor and the Prospects
          at Rep.'s own expense.  As Rep.'s remuneration and on a monthly basis,
          Rep.  will receive from  Licensor  for such  services a commission  as
          documented on Schedule A, attached  hereto and made a part hereof,  or
          as otherwise  agreed in writing by Licensor and Rep. on an  individual
          Prospect basis.  The commission due and payable for each Prospect will
          be equal to either a flat fee for arranging a License agreement with a
          Prospect  or a  specified  percentage  of the "gross  sales  proceeds"
          (defined  below)  arising  from  the  use of each  Trillennium  System
          licensed  to  that  Prospect  by  Licensor  on  which  payment  for  a
          particular   underlying  invoice  is  actually  received  by  Licensor
          (collectively,  the  "Commissions").  Commissions  (as opposed to flat
          fees for  establishment  of License a License  Agreement  with  Rep.'s
          prospect) will only be due and payable once an underlying invoice with
          respect to a particular Prospect has been paid in full to Licensor, or
          if not paid in full then once an amount  mutually  agreed upon between
          Licensor  and the  Prospect  has been  received  by  Licensor  on such
          invoice.

     b.   For  purposes  of this  Section,  "gross  sales  proceeds",  means the
          aggregate  payment  actually  received  by  Licensor  on a  particular
          invoice for use of the  Trillennium  System under the invoice,  net of
          all sales or use taxes.

     c.   Licensor will make payment of the gross aggregate Commissions due Rep.
          for a particular month, if any, within fifteen (15) days of the end of
          such month.  In addition,  at the time of such payment,  Licensor will
          disclose in writing to Rep. the  underlying  gross sales  proceeds for
          each  Prospect and a statement of the  underlying  Commission  due (or
          Commission  refund  owed by) Rep.  for each  Prospect  (a  "Commission
          Statement").

     d.   The obligation to pay commissions  arising from any License  Agreement
          entered into between  Licensor and Rep.'s  Prospect(s)  shall  survive
          termination of this  Agreement,  except in the event this Agreement is
          terminated  due to Rep's  malfeasance or other breach of the terms and
          conditions hereof.

          e.   Rep., by its duly authorized agents and/or representatives,  will
               have the right for six (6) months from the date of any Commission
               Statement  to audit  those  records  of  Licensor  related to the
               Commission  Statement in order to verify that Commissions due and
               owing Rep. associated with the invoices covered by the Commission
               Statement  were correctly  calculated and paid (an "Audit").  All
               Audits will be  conducted  at Rep.'s sole  expense at  Licensor's
               premises  during normal business hours. An Audit may be conducted
               only upon at least five (5) business days' advance written notice
               to Licensor.  Rep.  will conduct any Audits in such manner as not
               to delay or interfere with  Licensor's  business and  operations.
               Rep. will provide  Licensor  within fifteen (15) business days of
               the Audit, Rep.'s written findings regarding the Audit.  Licensor
               will have fifteen (15) business days from the date of its receipt
               of Rep.'s written Audit findings to provide Rep. with  Licensor's
               written  response  to such  findings.  If any Audit  finding,  as
               agreed by the parties,  reveals an  underpayment,  Licensor  will
               immediately  pay the  underpaid  amount  to  Rep..  If any  Audit
               finding, as agreed by the parties,  reveals an overpayment,  Rep.
               will immediately pay the overpaid amount to Licensor.

                                       4
<PAGE>
9.   Independent  Contractor The parties acknowledge that they will be acting as
     independent  contractors  and  not as  employees  of one  another  for  all
     purposes,  including  payment of Social Security,  Medicare,  employment or
     unemployment  tax, and any other  federal,  state and local taxes.  Neither
     party  will  have a claim  against  the other  for any  employee  benefits,
     including but not limited to leave benefits,  retirement benefits, worker's
     compensation  benefits,  or unemployment  insurance benefits.  Rep. will be
     responsible and have exclusive  liability for payment of any taxes relating
     to the Commissions paid to Rep. under this Agreement.  In accomplishing its
     functions  pursuant to this Agreement,  the parties  acknowledge  that Rep.
     will not be a party to any contract  for the  licensing or sale of goods or
     services between Licensor and the Prospects.

10.  Prohibition on Representations or Warranties. Neither Rep. nor Licensor has
     the  authority,   whether  express  or  implied,  to  bind  the  other.  In
     furtherance  of the  foregoing  Rep.  agrees  that it will  not  under  any
     circumstances or in any manner: (i) make any Representations or Warranties,
     or (ii) negotiate any terms or conditions of any arrangement,  on behalf of
     Licensor.

11.  Term. The initial term of this  Agreement  shall be for a period of two (2)
     years and shall begin on the Commencement  Date unless sooner terminated by
     written  notice  provided by either party no less than 60 days prior to the
     date  of  intended  termination.  In the  event  Rep.  is  responsible  for
     generating a minimum of fifty (50) Prospects with whom Licensor has entered
     into  Licensee  Agreements  during  the  initial  two (2) year  term,  this
     Agreement  shall, at Rep.'s option,  be extended for an additional five (5)
     years on the same terms and conditions as set forth herein.

12.  Indemnification.  Rep.  agrees  to and  shall  indemnify,  defend  and hold
     harmless  Licensor  from any and all  claims,  damages  and  attorney  fees
     arising  from the  investigation  or defense of any claim  brought  against
     Licensor  as a result of any claims for  personal  injury or other  damage,
     products  liability claims, or other claims of any kind or nature resulting
     from Rep.'s activities with,  related to or otherwise arising from, the use
     of Trillennium  Services or the  interpretation  of any images generated by
     the  Trillennium  System.  This provision  shall survive the termination of
     this Agreement.

13.  Termination.  This Agreement  shall  terminate upon the earlier to occur of
     the following:

     a.   Expiration of the term set forth in section 13 hereof;

     b.   Immediately at the option of the Licensor in the event Rep. shall fail
          to fulfill any of its  obligations  under this  Agreement or any other
          agreement between Licensor and Rep.;

     c.   Immediately  upon Rep.'s ceasing to do business,  making an assignment
          for the benefit of creditors,  voluntarily  seeking  protection  under
          bankruptcy or similar  laws,  entering  into a  composition,  becoming
          insolvent,  or if an order liquidating the Rep. is issued from a court
          of competent  jurisdiction.  Rep. shall immediately notify Licensor in
          writing of any of the events referenced in this subparagraph.

     d.   Immediately  upon  Licensor's  ceasing  to  do  business,   making  an
          assignment  for the benefit of  creditors,  seeking  protection  under
          bankruptcy or similar  laws,  entering  into a  composition,  becoming
          insolvent,  or if an order  liquidating  the Licensor is issued from a
          court of competent  jurisdiction.  Licensor shall  immediately  notify
          Rep. in writing of any of the events referenced in this  subparagraph.
          Notwithstanding  the  foregoing,  this  Agreement  shall not terminate
          automatically and, at Rep.'s option,  shall continue in full force and
          effect,  if the holder of debt or trustee in  bankruptcy  accepts this
          Agreement as executory, allowing Rep. to continue operation, including
          use of the Licensed Rights and other grants of rights  hereunder,  and
          the manner  originally  contemplated  by the  parties  hereto  without
          adverse effect on the rights and obligations created hereunder.

                                       5
<PAGE>
14.  Rights and Obligations upon Termination.

     a.   Upon expiration or sooner  termination of the terms of this Agreement,
          and without  regard to the cause thereof,  all rights,  privileges and
          obligations  shall cease and terminate and the Rep.'s rights to market
          the Licensed  Rights and  Trillennium  System  and/or  Services  shall
          immediately  cease and be deemed to have  reverted  back to  Licensor,
          provided however,  that no termination of this Agreement by expiration
          or  otherwise  shall  rescind  or give rise to any  rights to  rescind
          anything  done or any  payment  made or other  consideration  given to
          either  party  hereunder  prior to the time such  termination  becomes
          effective.

     b.   The provisions of this Agreement,  which are specifically  intended to
          survive  the  termination  of this  Agreement,  shall  continue  to be
          applicable.

     c.   Immediately  upon  termination  for any reason,  Rep. shall, at Rep.'s
          sole expense,  immediately  and in a commercially  reasonable  manner,
          return  all  Licensor's  property,  including  but not  limited to all
          Thermal  Imaging  Cameras  and  related  hardware  and/or  software to
          Licensor at such address or addresses as Licensor  shall  designate to
          Rep. in  writing.  In the event Rep.  fails to return all  property to
          Licensor as aforesaid Licensor shall, at Rep.'s sole expense, have the
          unrestricted  right  to  enter  upon  Rep.'s  premise(s)  and  to in a
          commercially   reasonable   manner  remove  all  Licensor's   property
          including but not limited to its Thermal  Imaging  Cameras and related
          hardware and/or software.

15.  Notices.  All notices or other  communications  given under this  Agreement
     shall  be in  writing  and  delivered  personally,  telefaxed,  be  sent by
     certified mail, return receipt requested,  postage prepaid, or be sent by a
     nationally or  internationally  recognized  courier  service,  with charges
     billed to or prepaid by the sender of such  notice,  and shall be addressed
     to the party to whom such notice is given as follows:

         If to Licensor:                    Mr. John A. Antonio
         ---------------
                                            President
                                            Trillennium Medical Imaging, Inc.
                                            6911 Pilliod Rd.
                                            Holland, Ohio 43528

         With a copy to:                    Norman A. Abood, Esq.
                                            3306 Executive Parkway, Suite 205
                                            Toledo, Ohio 43606

         If to Rep.:                        Allevia Medical
                                            Attn. Marty Ellis

         With a copy to:



or to such other address and to the attention of such other persons indicated in
a subsequent notice given in accordance with this paragraph. Any notice given in
accordance  with this paragraph shall be deemed to have been given when received
or the date noted as the date delivery was refused or the date noted as the date
when delivery was unsuccessfully  attempted if delivery by the Postal Service or
a third-party courier or when telefaxed, provided acknowledgment of transmission
is evidenced by the telefaxed transmitting the same.

16.  No Joint Venture.  Nothing herein contained shall be construed to place the
     parties in the  relationship  of partners or joint  venturers,  and neither
     Licensor nor Rep.  shall have the power to obligate or bind the other party
     in any manner whatsoever.

17.  Binding  Effect/Merger.  This Agreement  shall be binding upon and inure to
     the  benefit of the  parties  hereto  and their  permitted  successors  and
     assigns.  The parties agree that the terms and conditions  hereof supersede
     any and all prior negotiations and/or representations by either party, made
     by any of their respective officers,  employees, agents or representatives,
     whether verbal or written.

                                       6
<PAGE>
18.  Time Is of the Essence. Time shall be of the essence with respect to all of
     Licensor's and Rep.'s obligations and duties hereunder,  all of which shall
     be  performed  and honored  strictly in  accordance  with the terms of this
     Agreement  notwithstanding  any prior,  continuing or subsequent  course of
     dealing, custom or usage in trade.

19.  Severability  Should any term or provision of this  Agreement be determined
     by any court to be illegal or in  conflict  with any  applicable  law,  the
     validity  of the  remaining  terms  and  provisions  hereof,  shall  not be
     affected  thereby.  Such remaining terms and provisions hereof shall remain
     in full force and effect as if this  Agreement  had been  executed with the
     invalid  portion thereof  eliminated.  It is hereby declared by the parties
     hereto that they would have executed the remaining  terms and provisions of
     this Agreement  without  including herein any such terms or provisions that
     may hereafter for any reasons be determined invalid.

20.  Modification  and Waiver This  Agreement  may not be  altered,  modified or
     amended, nor shall any waiver or consent be binding on either party, unless
     in writing and  executed by both Rep.  and  Licensor.  The waiver by either
     party of any breach of any provision of this Agreement shall not operate or
     be construed as a waiver of any subsequent  breach of the same or any other
     provision hereof.

21.  Governing  Laws.  The  terms  of  this  Agreement  shall  be  governed  by,
     construed,  and interpreted  under the laws of the United States of America
     and the State of Ohio without  regard to the principles of conflict of law.
     Both parties represent they have been independently  represented by counsel
     in the  preparation of this  Agreement;  as such,  this Agreement  shall be
     deemed to have been jointly  written by the parties and neither party shall
     be  deemed  to be the  preparer  of  this  Agreement.  The  forum  for  all
     litigation shall be within the County of Lucas, State of Ohio.

IN WITNESS WHEREOF,  the parties have executed this Agreement  effective the day
and year first written above.

Licensor:                          Trillennium Medical Imaging, Inc.

                                   By: /s/ John A. Antonio
                                   ------------------------
                                   John A. Antonio
                                   Title:  President

Rep.:                              Allevia Medical

                                   By: /s/ Marty Ellis
                                   --------------------
                                   Marty Ellis
                                   Title:  President





                                       7